These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16188951)

  • 21. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.
    Wurch T; Boutet-Robinet EA; Palmier C; Colpaert FC; Pauwels PJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):380-90. PubMed ID: 12490615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential inverse agonism at the human muscarinic M₃ receptor.
    Casarosa P; Kiechle T; Bakker RA
    Methods Enzymol; 2010; 485():81-101. PubMed ID: 21050912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of partial agonists and Mg2+ ions on the interaction of M2 muscarinic acetylcholine receptor and G protein Galpha i1 subunit in the M2-Galpha i1 fusion protein.
    Zhang Q; Okamura M; Guo ZD; Niwa S; Haga T
    J Biochem; 2004 May; 135(5):589-96. PubMed ID: 15173197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor.
    Thor D; Schulz A; Hermsdorf T; Schöneberg T
    Biochem J; 2008 May; 412(1):103-12. PubMed ID: 18237275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double mutant cycle analysis of aspartate 69, 97, and 103 to asparagine mutants in the m2 muscarinic acetylcholine receptor.
    Vogel WK; Peterson GL; Broderick DJ; Mosser VA; Schimerlik MI
    Arch Biochem Biophys; 1999 Jan; 361(2):283-94. PubMed ID: 9882458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor.
    Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice.
    Yamada S; Maruyama S; Takagi Y; Uchida S; Oki T
    Life Sci; 2006 Dec; 80(2):127-32. PubMed ID: 16996089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner.
    Steinfeld T; Hughes AD; Klein U; Smith JA; Mammen M
    Mol Pharmacol; 2011 Mar; 79(3):389-99. PubMed ID: 21139051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
    Thomas RL; Langmead CJ; Wood MD; Challiss RA
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
    Langmead CJ; Fry VA; Forbes IT; Branch CL; Christopoulos A; Wood MD; Herdon HJ
    Mol Pharmacol; 2006 Jan; 69(1):236-46. PubMed ID: 16207821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis.
    Spalding TA; Burstein ES; Brauner-Osborne H; Hill-Eubanks D; Brann MR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1274-9. PubMed ID: 8531092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
    McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
    Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of serotonin 5-HT2C receptors by chronic ligand exposure.
    Devlin MG; Smith NJ; Ryan OM; Guida E; Sexton PM; Christopoulos A
    Eur J Pharmacol; 2004 Sep; 498(1-3):59-69. PubMed ID: 15363976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chlorpyrifos oxon on M2 muscarinic receptor internalization in different cell types.
    Udarbe Zamora EM; Liu J; Pope CN
    J Toxicol Environ Health A; 2008; 71(21):1440-7. PubMed ID: 18800293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M(2) and M(4) muscarinic receptors in rat brain.
    Machová E; Jakubík J; El-Fakahany EE; Dolezal V
    J Pharmacol Exp Ther; 2007 Jul; 322(1):316-23. PubMed ID: 17446301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of M1 muscarinic receptors expressed in CHOm1 cells by panaxynol via cAMP pathway.
    Hao W; Xing-Jun W; Yong-Yao C; Liang Z; Yang L; Hong-Zhuan C
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):121-6. PubMed ID: 15936523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.
    Vogel WK; Sheehan DM; Schimerlik MI
    Mol Pharmacol; 1997 Dec; 52(6):1087-94. PubMed ID: 9415719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of nematode G protein GOA-1 by the human muscarinic acetylcholine receptor M2 subtype. Functional coupling of G-protein-coupled receptor and G protein originated from evolutionarily distant animals.
    Minaba M; Ichiyama S; Kojima K; Ozaki M; Kato Y
    FEBS J; 2006 Dec; 273(24):5508-16. PubMed ID: 17087737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor.
    Ding Z; Kim S; Kunapuli SP
    Mol Pharmacol; 2006 Jan; 69(1):338-45. PubMed ID: 16234484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reciprocal regulation of agonist and inverse agonist signaling efficacy upon short-term treatment of the human delta-opioid receptor with an inverse agonist.
    Piñeyro G; Azzi M; deLéan A; Schiller PW; Bouvier M
    Mol Pharmacol; 2005 Jan; 67(1):336-48. PubMed ID: 15496503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.